ES2071016T3 - Derivados de piridazinona. - Google Patents

Derivados de piridazinona.

Info

Publication number
ES2071016T3
ES2071016T3 ES90305015T ES90305015T ES2071016T3 ES 2071016 T3 ES2071016 T3 ES 2071016T3 ES 90305015 T ES90305015 T ES 90305015T ES 90305015 T ES90305015 T ES 90305015T ES 2071016 T3 ES2071016 T3 ES 2071016T3
Authority
ES
Spain
Prior art keywords
compounds
pyrido
pyridazine
oxo
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90305015T
Other languages
English (en)
Inventor
Banavara Lakshmana Mylari
William James Zembrowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of ES2071016T3 publication Critical patent/ES2071016T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

UNA SERIE DE NUEVOS COMPUESTOS DEL ACIDO 6-SUSTITUIDO-5-OXO-6H-PIRIDO (2,3-D)PIRIDAZINA-8-ILACETICO Y DEL ACIDO 7-SUSTITUIDO-8-OXO-7H-PIRIDO (2,3-D) PIRIDAZINA-5-ILACETICO SON PREPARADOS INCLUYENDO SUS DERIVADOS DEL ESTER DE C1-C6 ALQUIL, ASI COMO LAS SALES ACIDAS Y BASICAS CON CATIONES FARMACOLOGICAMENTE ACEPTABLES. LOS COMPUESTOS INCLUYEN AQUELLOS ACIDOS EN LOS QUE EL SUSTITUYENTE DEL ANILLO ESTA SIEMPRE UNIDO AL ATOMO DE NITROGENO DEL ANILLO DISPONIBLE, Y ES O UN GRUPO ARALQUIL INFERIOR O UN GRUPO HETEROARALQUIL INFERIOR. ESTOS COMPUESTOS SE UTILIZAN COMO INHIBIDORES DE LA ALDOSA REDUCTASA, PARA EL CONTROL DE CIERTAS COMPLICACIONES DE LA DIABETES CRONICA. SE PROPORCIONAN METODOS PARA PREPARAR ESTOS COMPUESTOS A PARTIR DE MATERIALES CONOCIDOS.
ES90305015T 1989-05-11 1990-05-10 Derivados de piridazinona. Expired - Lifetime ES2071016T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/350,417 US4996204A (en) 1989-05-11 1989-05-11 Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors

Publications (1)

Publication Number Publication Date
ES2071016T3 true ES2071016T3 (es) 1995-06-16

Family

ID=23376622

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90305015T Expired - Lifetime ES2071016T3 (es) 1989-05-11 1990-05-10 Derivados de piridazinona.

Country Status (18)

Country Link
US (1) US4996204A (es)
EP (1) EP0401981B1 (es)
JP (1) JPH0631235B2 (es)
KR (1) KR920003559B1 (es)
AT (1) ATE121743T1 (es)
AU (1) AU611610B2 (es)
CA (1) CA2016326C (es)
DE (1) DE69018876T2 (es)
DK (1) DK0401981T3 (es)
ES (1) ES2071016T3 (es)
FI (1) FI93013C (es)
HU (1) HU206714B (es)
IE (1) IE66029B1 (es)
IL (1) IL94302A (es)
NO (1) NO173938C (es)
NZ (1) NZ233599A (es)
PT (1) PT93984B (es)
ZA (1) ZA903564B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
US5716954A (en) * 1991-10-09 1998-02-10 Syntex U.S.A. Inc. Benzopyridazinone and pyridopyridazinone compounds
JP2789134B2 (ja) * 1992-09-28 1998-08-20 ファイザー・インク． 糖尿病の合併症を制御する置換ピリミジン類
GB9314412D0 (en) * 1993-07-13 1993-08-25 Rhone Poulenc Agriculture New compositions of matter
CN1205207C (zh) * 1998-03-31 2005-06-08 药品发现学会公司 取代的吲哚链烷酸
TNSN99224A1 (fr) 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
MXPA03004871A (es) * 2000-11-30 2003-08-19 Pfizer Prod Inc Combinacion de agonistas de gaba e inhibidores de aldosa-reductasa.
DE60204611T2 (de) 2001-02-28 2006-05-11 Pfizer Products Inc., Groton Sulfonyl-pyridazinon-derivate zur Verwendung als Aldose-reduktase-inhibitoren
IL156462A0 (en) * 2001-03-30 2004-01-04 Pfizer Prod Inc Pyridazinone aldose reductase inhibitors
JP2004528344A (ja) * 2001-04-30 2004-09-16 ファイザー・プロダクツ・インク アルドースレダクターゼ阻害薬とシクロオキシゲナーゼ−２阻害薬の併用
AU761191B2 (en) 2001-05-24 2003-05-29 Pfizer Products Inc. Therapies for tissue damage resulting from ischemia
US7572910B2 (en) * 2003-02-20 2009-08-11 Pfizer, Inc. Pyridazinone aldose reductase inhibitors
US8916563B2 (en) * 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
JP5934206B2 (ja) * 2010-07-16 2016-06-15 ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク アルドース還元酵素阻害剤および同使用方法
BR112018076244A2 (pt) 2016-06-21 2019-03-26 The Trustees Of Columbia University In The City Of New York inibidores da aldose redutase e métodos de uso destes
PL3658142T3 (pl) 2017-07-28 2024-08-26 Applied Therapeutics, Inc. Związki i sposoby leczenia galaktozemii
SG11202111822QA (en) 2019-05-07 2021-11-29 Univ Miami Treatment and detection of inherited neuropathies and associated disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
DE2708187A1 (de) * 1977-02-25 1978-08-31 Thomae Gmbh Dr K Neue pyrido-pyridazin-one
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4209527A (en) * 1979-05-16 1980-06-24 Pfizer Inc. Benzimidazolone derivatives
CA1160518A (en) * 1979-07-06 1984-01-17 E. I. Du Pont De Nemours And Company Coated cookware with fep topcoat
ES2032749T3 (es) * 1985-11-07 1993-03-01 Pfizer Inc. Acidos oxoftalazinil-aceticos heterociclicos.
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof

Also Published As

Publication number Publication date
HU902996D0 (en) 1990-09-28
NO902070L (no) 1990-11-12
IL94302A (en) 1994-01-25
AU5490590A (en) 1990-11-15
PT93984B (pt) 1996-11-29
IE901701L (en) 1990-11-11
NO173938C (no) 1994-02-23
NO902070D0 (no) 1990-05-10
DK0401981T3 (da) 1995-09-04
KR920003559B1 (ko) 1992-05-04
CA2016326A1 (en) 1990-11-11
AU611610B2 (en) 1991-06-13
EP0401981B1 (en) 1995-04-26
CA2016326C (en) 1995-05-30
NZ233599A (en) 1991-07-26
DE69018876D1 (de) 1995-06-01
ATE121743T1 (de) 1995-05-15
FI93013B (fi) 1994-10-31
DE69018876T2 (de) 1995-08-24
HUT54683A (en) 1991-03-28
JPH0631235B2 (ja) 1994-04-27
US4996204A (en) 1991-02-26
KR900018092A (ko) 1990-12-20
NO173938B (no) 1993-11-15
EP0401981A1 (en) 1990-12-12
JPH035481A (ja) 1991-01-11
FI93013C (fi) 1995-02-10
IL94302A0 (en) 1991-03-10
HU206714B (en) 1992-12-28
ZA903564B (en) 1992-08-26
PT93984A (pt) 1991-01-08
IE66029B1 (en) 1995-11-29
FI902335A0 (fi) 1990-05-10

Similar Documents

Publication Publication Date Title
ES2071016T3 (es) Derivados de piridazinona.
IE871843L (en) Indolinone derivatives.
DE3071230D1 (en) Substituted 6-phenethyl-and phenylethenyl-3,4,5,6-tetrahydro-4-hydroxytetraydropyran-2-ones in the4-r trans stereoisomeric forms and the corresponding dihydroxy acids, process for preparing and pharmaceutical composition comprising them
IE801005L (en) Benzimidazolones.
HUT62855A (en) Process for producing glycerol derivatives and pharmaceutical compositions comprising same
EG18597A (en) Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate
JPS6429363A (en) Heterocyclic derivative

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 401981

Country of ref document: ES